A range exists, but the evidence is preliminary
The range above is what studies or protocols have used, but no human trial has established that KPV is effective at it. Converting a dose does not make the dose validated. See the graded evidence on the KPV profile before relying on any figure here.
Convert your KPV dose
Vial
Result
Converted amount0.2 mg
Dose mass200 mcg
Concentration2,500 mcg/mL
Draw volume0.08 mL
U-100 syringe8 units
Reported study ranges
| Purpose | Route | Reported range | Frequency |
|---|---|---|---|
| anti-inflammatory / gut health | oral | 200–500 mcg | 1-2x daily |
| systemic inflammation | subcutaneous | 200–500 mcg | daily |
Ranges are reported from the literature for research context only. They are not a protocol and not a recommendation.
Concentration by vial and diluent
| Vial | 1 mL diluent | 2 mL diluent | 3 mL diluent |
|---|---|---|---|
| 2 mg | 2,000 mcg/mL | 1,000 mcg/mL | 667 mcg/mL |
| 5 mg | 5,000 mcg/mL | 2,500 mcg/mL | 1,667 mcg/mL |
| 10 mg | 10,000 mcg/mL | 5,000 mcg/mL | 3,333 mcg/mL |
Concentration is vial mass divided by diluent volume. Reconstitution volume changes what you draw, never the dose itself.
What to draw for 200 mcg
| Vial | Diluent | Draw volume | U-100 units | Doses per vial |
|---|---|---|---|---|
| 2 mg | 1 mL | 0.1 mL | 10 units | 10 |
| 2 mg | 2 mL | 0.2 mL | 20 units | 10 |
| 2 mg | 3 mL | 0.3 mL | 30 units | 10 |
| 5 mg | 1 mL | 0.04 mL | 4 units | 25 |
| 5 mg | 2 mL | 0.08 mL | 8 units | 25 |
| 5 mg | 3 mL | 0.12 mL | 12 units | 25 |
| 10 mg | 1 mL | 0.02 mL | 2 units | 50 |
| 10 mg | 2 mL | 0.04 mL | 4 units | 50 |
| 10 mg | 3 mL | 0.06 mL | 6 units | 50 |
Calculated for the low end of the reported anti-inflammatory / gut health range. Change the dose in the calculator above for any other amount.
KPV at a glance
~15-30 minutes (estimated)
Half-life
342.43 Da
Molecular weight
oral, subcutaneous, topical
Routes
reclassification pending
Legal status